UDP-Glucuronosyltransferase 2B7 C802T (His₂₆₈Tyr) Polymorphism in Bladder Cancer Cases

REFERENCES

• Bhasker , C. R. , McKinnon , W. , Stone , A. , Lo , A. C. , Kubota , T. , Ishizaki , T. and Miners , J. O. 2000 . Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: Ethnic diversity of alleles and potential clinical significance . Pharmacogenetics , 10 : 679 – 685 .
   PubMedGoogle Scholar
• Ciotti , M. , Lakshmi , V. M. , Basu , N. , Davis , B. B. , Owens , I. S. and Zenser , T. V. 1999 . Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferase and pH stability of glucuronides . Carcinogenesis , 20 : 1963 – 1969 .
   PubMed Web of Science ®Google Scholar
• Golka , K. , Prior , V. , Blaszkewicz , M. and Bolt , H. M. 2002 . The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: A review considering ethnic differences . Toxicol. Lett. , 128 : 229 – 241 .
   PubMed Web of Science ®Google Scholar
• Guillemette , C. 2003 . Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics . J. , 3 : 136 – 158 .
   Google Scholar
• Guillemette , C. , Millikan , R. C. , Newman , B. and Housman , D. E. 2000 . Genetic polymorphisms in uridine diphospho-glucuronosyltransferase IAI and association with breast cancer among African Americans . Cancer Res. , 60 : 950 – 956 .
   PubMed Web of Science ®Google Scholar
• Holthe , M. , Klepstad , P. , Zahlsen , K. , Borchgrevink , P. C. , Hagen , L. , Dale , O. , Kaasa , S. , Krokan , H. E. and Skorpen , F. 2002 . Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1∗28 polymorphisms in cancer patients on chronic morphine therapy . Eur. J. Clin. Pharmacol. , 58 : 353 – 356 .
   PubMed Web of Science ®Google Scholar
• Jin , C. J. , Miners , J. O. , Burchell , B. and Mackenzie , P. I. 1993a . The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases . Carcinogenesis , 14 : 2637 – 2639 .
   PubMed Web of Science ®Google Scholar
• Jin , C. J , Miners , J. O. , Lillywhite , K. J. and Mackenzie , P. I. 1993b . Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs . J. Pharmacol. Exp. Ther. , 264 : 475 – 479 .
   PubMed Web of Science ®Google Scholar
• Lampe , J. W. , Bigler , J. , Bush , A. C. and Potter , J. D. 2000 . Prevalence of polymorphism in the human UDP-glucuronosyltransferase 2B family: UGT2B4 (D458E), UGT2B7 (H268Y), and UGT2B15 (D85Y). Cancer Epidemiol. Biomarkers . Prev. , 9 : 329 – 333 .
   Google Scholar
• Lin , G. F. , Guo , W. C , Chen , J. G. , Qin , Y. Q. , Golka , K. , Xiang , C. Q. , Ma , Q. W. , Lu , D. R. and Shen , J. H. 2005 . An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China . Toxicol. Sci. , 85 : 502 – 506 .
   PubMed Web of Science ®Google Scholar
• Mackenzie , P. I. , Bock , K. W. , Burchell , B. , Guillemette , C. , Ikushiro , S. , Iyanagi , T. , Miners , J. O. , Owens , I. S. and Nebert , D. W. 2005 . Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily . Pharmacogenet. Genomics , 15 : 677 – 685 .
   PubMed Web of Science ®Google Scholar
• Mackenzie , P. I. , Owens , I. S. , Burchell , B. , Bock , K. W. , Bairoch , A. , Belanger , A. , Fournel-Gigleux , S. , Green , M. , Hum , D. W. , Iyanagi , T. , Lancet , D. , Louisot , P. , Magdalou , J. , Chowdhury , J. R. , Ritter , J. K. , Schachter , H. , Tephly , T. R. , Tipton , K. F. and Nebert , D. W. 1997 . The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence . Pharmacogenetics , 7 : 255 – 269 .
   PubMedGoogle Scholar
• Ockenga , J. , Vogel , A. , Teich , N. , Keim , V. , Manns , M. P. and Strassburg , C. P. 2003 . UDP glucuronosyltransferase (UGTIA7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer . Gastroenterology , 124 : 1802 – 1808 .
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya , A. , Little , J. M. and Czernik , P. I. 2001 . Human UDP-glucuronosyltransferase 2B7 . Curr. Drug. Metab. , 2 : 283 – 289 .
   PubMed Web of Science ®Google Scholar
• DevelopmentR Core Team. 2004. R: A language and environment for statistical computing. R-Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org
   Google Scholar
• Vineis , P. , Marinelli , D. , Autrup , H. , Brockmöller , J. , Cascorbi , I. , Daly , A. K. , Golka , K. , Okkels , H. , Risch , A. , Rothman , N. , Sim , E. and Taioli , E. 2001 . Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: A pooled analysis of genotype-based studies . Cancer Epidemiol. Biomarkers Prev. , 10 : 1249 – 1252 .
   PubMed Web of Science ®Google Scholar
• Wallig , M. A. 2004 . Glucuronidation and susceptibility to chemical carcinogenesis . Toxicol. Sci. , 78 : 1 – 2 .
   PubMed Web of Science ®Google Scholar
• Zenser , T. V. , Lakshmi , V. M. , Hsu , F. F. and Davis , B. B. 2002 . Metabolism of N-acetylbenzidine and initiation of bladder cancer . Mutat. Res. , 506–507 : 29 – 40 .
   PubMed Web of Science ®Google Scholar
• Zheng , Z. , Fang , J. L. and Lazarus , P. 2002 . Glucuronidation: An important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues . Drug Metab. Dispos. , 30 : 397 – 403 .
   PubMed Web of Science ®Google Scholar
• Zheng , Z. , Park , J. Y. , Guillemette , C. , Schantz , S. P. and Lazarus , P. 2001 . Tobacco carcinogene-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk . J. Natl. Cancer Inst. , 93 : 1411 – 1418 .
   PubMed Web of Science ®Google Scholar